SGLT-2 inhibitors in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus: a systematic review
Ortiz, The risk for urinary tract infections with sodium-glucose cotransporter 2 inhibitors: no longer a cause of concern
It describes sequential monotherapy as transitioning from one agent to another rather than running both at once, with providers tapering one before initiating the other
You must understand the factors to realize the California legal BAC limit
The study authors identified a second variant, rs1800437, this time in the GIPR gene, that was also associated with worse nausea and vomiting but only in people taking tirzepatide
Erythrocytosis, the elevation of hematocrit above 52 percent, requires regular monitoring and may necessitate therapeutic phlebotomy